Sistemas Genómicos Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Employees
-
110
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Sistemas Genómicos General Information
Description
Operator of molecular biology and genetic research firm intended to develop next-generation sequencing for genetic diagnosis. The company specializes in reproductive health, pharmacogenetics, translational research and development and bioinformatics, empowering healthcare professionals with the necessary tools to complete the diagnostic process quickly and efficiently.
Contact Information
Website
www.sistemasgenomicos.com(Operating Subsidiary)
Corporate Office
- Parque Tecnológico de Paterna R. Guillermo Marconi, 6
- R. Guglielmo Marconi 6
- 46980 Valencia
- Spain
Corporate Office
- Parque Tecnológico de Paterna R. Guillermo Marconi, 6
- R. Guglielmo Marconi 6
- 46980 Valencia
- Spain
Sistemas Genómicos Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sistemas Genómicos Comparisons
Industry
Financing
Details
Sistemas Genómicos Competitors (1)
One of Sistemas Genómicos’s competitors is Sequentia Biotech, a Venture Capital-Backed company based in Barcelona, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sequentia Biotech | Venture Capital-Backed | Barcelona, Spain |
Sistemas Genómicos Patents
Sistemas Genómicos Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4031688-A1 | In vitro method for determining the risk of developing breast cancer in a subject | Active | 22-Oct-2019 | ||
| EP-4031688-B1 | In vitro method for determining the risk of developing breast cancer in a subject | Active | 22-Oct-2019 | ||
| EP-4031688-C0 | In vitro method for determining the risk of developing breast cancer in a subject | Active | 22-Oct-2019 | ||
| WO-2021078794-A1 | In vitro method for determining the risk of developing breast cancer in a subject | Inactive | 22-Oct-2019 | ||
| EP-3884502-A1 | Method and computer program product for analysis of fetal dna by massive sequencing | Active | 19-Nov-2018 | G16B20/10 |
Sistemas Genómicos Signals
Sistemas Genómicos Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Sistemas Genómicos FAQs
-
When was Sistemas Genómicos founded?
Sistemas Genómicos was founded in 1998.
-
Where is Sistemas Genómicos headquartered?
Sistemas Genómicos is headquartered in Valencia, Spain.
-
What is the size of Sistemas Genómicos?
Sistemas Genómicos has 110 total employees.
-
What industry is Sistemas Genómicos in?
Sistemas Genómicos’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Sistemas Genómicos a private or public company?
Sistemas Genómicos is a Private company.
-
What is the current valuation of Sistemas Genómicos?
The current valuation of Sistemas Genómicos is .
-
What is Sistemas Genómicos’s current revenue?
The current revenue for Sistemas Genómicos is .
-
Who are Sistemas Genómicos’s investors?
Ascires Biomedical Group has invested in Sistemas Genómicos.
-
Who are Sistemas Genómicos’s competitors?
Sequentia Biotech is a competitor of Sistemas Genómicos.
-
When was Sistemas Genómicos acquired?
Sistemas Genómicos was acquired on 04-Jan-2022.
-
Who acquired Sistemas Genómicos?
Sistemas Genómicos was acquired by SYNLAB International.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process